Prof. Dr. Lafosse and RevArte Featured in Belgian Media for Integrating neuroClues® in Neurorehabilitation
At RevArte in Edegem, clinicians are exploring how eye movements can reveal neurological disorders years before symptoms …
neuroClues is ISO27001:2022 certified ensuring the security of patient & hospital data
Since April 3rd 2026 neuroClues is certified ISO27001:2022 for Information Security Management Systems by AFNOR. This ce …
neuroClues® raises a Series A of 10M€ to accelerate its commercialization
Brussels & Paris, March 31, 2026 – Months after receiving CE certification for its Class IIa medical device, neuroCl …
